175 General Discussion 33. Wilson JM, Jungner YG. [Principles and practice of mass screening for disease]. Bol Oficina Sanit Panam. 1968; 65: 281-393. 34. Chalmers E, Williams M, Brennand J, Liesner R, Collins P, Richards M, Paediatric Working Party of United Kingdom Haemophilia Doctors O. Guideline on the management of haemophilia in the fetus and neonate. Br J Haematol. 2011; 154: 208-215. 35. Kadir RA, Economides DL, Braithwaite J, Goldman E, Lee CA. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol. 1997; 104: 803-810. 36. Kulkarni R, Presley RJ, Lusher JM, Shapiro AD, Gill JC, Manco-Johnson M, Koerper MA, Abshire TC, DiMichele D, Hoots WK, Mathew P, Nugent DJ, Geraghty S, Evatt BL, Soucie JM. Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System. Haemophilia. 2017; 23: 207-214. 37. Chalmers EA, Alamelu J, Collins PW, Mathias M, Payne J, Richards M, Tunstall O, Williams M, Palmer B, Mumford A, Paediatric, Rare Disorders Working Parties of the UKHDO. Intracranial haemorrhage in children with inherited bleeding disorders in the UK 2003-2015: A national cohort study. Haemophilia. 2018; 24: 641-647. 38. Moorehead PC. Considering the benefits of newborn screening for haemophilia. Haemophilia. 2019; 25: e298-e299. 39. Gelb MH, Basheeruddin K, Burlina A, Chen HJ, Chien YH, Dizikes G, Dorley C, Giugliani R, Hietala A, Hong X, Kao SM, Khaledi H, Klug T, Kubaski F, Liao HC, Martin M, Manning A, Orsini J, Peng Y, Ranieri E, Rohrwasser A, Szabo-Fresnais N, Turgeon CT, Vaz FM, Wang LY, Matern D. Liquid ChromatographyTandem Mass Spectrometry in Newborn Screening Laboratories. Int J Neonatal Screen. 2022; 8: 62. 40. Verkaik-Kloosterman J. Neonatal heel prick screening TSH concentration in the Netherlands as indicator of iodine status. Nutr J. 2021; 20: 63. 41. van Dijk T, Kater A, Jansen M, Dondorp WJ, Blom M, Kemp S, Langeveld M, Cornel MC, van der Pal SM, Henneman L. Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective. Front Pediatr. 2021; 9: 706394. 42. Meystre S. The current state of telemonitoring: a comment on the literature. Telemed J E Health. 2005; 11: 63-69. 43. Sait H, Sajjan SM, Phadke SR. Haemophilia management programme: Transformation during COVID-19. Indian J Med Res. 2022; 155: 472-477. 44. Emani S, Nelson LT, Norton S, Singh R, Pamula V, Emani S. Enzymatic Functional Assays of Coagulation Using Small Sample Volumes. Lab Med. 2017; 49: 47-54. 45. Enzyre. Enzyre: Near Patient Diagnostics Focused on Blood Coagulation. https://enzyre.com/. Accessed on 20-10-2022. 46. Hu C, Annese VF, Giagkoulovits C, Barrett MP, Cumming DRS. Factor VIII companion diagnostic for haemophilia. Front Bioeng Biotechnol. 2022; 10: 1006600. 47. Boardman FK, Hale R, Young PJ. Newborn screening for haemophilia: The views of families and adults living with haemophilia in the UK. Haemophilia. 2019; 25: 276-282. 48. Boardman FK, Hale R, Gohel R, Young PJ. Preventing lives affected by hemophilia: A mixed methods study of the views of adults with hemophilia and their families toward genetic screening. Mol Genet Genomic Med. 2019; 7: e618. 9
RkJQdWJsaXNoZXIy MTk4NDMw